CAMP4 Therapeutics Corporation (CAMP) ROA
- 2026-06-30: ROA -114.79%.
- 2026-03-31: ROA -81.84%.
- 2025-12-31: ROA -68.25%.
- 2025-09-30: ROA -61.81%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -114.79% |
| 2026-03-31 | -81.84% |
| 2025-12-31 | -68.25% |
| 2025-09-30 | -61.81% |
| 2025-06-30 | -100.99% |
| 2025-03-31 | -82.47% |
| 2024-12-31 | -66.14% |
| 2024-09-30 | -241.07% |
| 2023-12-31 | -89.71% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -68.25% |
| 2024-12-31 | -66.14% |
| 2023-12-31 | -89.71% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |